Mechanically manipulating glymphatic transport by ultrasound combined with microbubbles.
Authors: Ye D, Chen S, Liu Y, Weixel C, Hu Z, Yuan J, Chen H
The glymphatic system is a perivascular fluid transport system for waste clearance. Glymphatic transport is believed to be driven by the perivascular pumping effect created by the pulsation of the arterial wall caused by the cardiac cycle. Ultrasound sonication of circulating microbubbles (MBs) in the cerebral vasculature induces volumetric expansion and contraction of MBs that push and pull on the vessel wall to generate a MB pumping effect. The objective of this study was to evaluate whether glymphatic transport can be mechanically manipulated by focused ultrasound (FUS) sonication of MBs. The glymphatic pathway in intact mouse brains was studied using intranasal administration of fluorescently labeled albumin as fluid tracers, followed by FUS sonication at a deep brain target (thalamus) in the presence of intravenously injected MBs. Intracisternal magna injection, the conventional technique used in studying glymphatic transport, was employed to provide a comparative reference. Three-dimensional confocal microscopy imaging of optically cleared brain tissue revealed that FUS sonication enhanced the transport of fluorescently labeled albumin tracer in the perivascular space (PVS) along microvessels, primarily the arterioles. We also obtained evidence of FUS-enhanced penetration of the albumin tracer from the PVS into the interstitial space. This study revealed that ultrasound combined with circulating MBs could mechanically enhance glymphatic transport in the brain.
Introduction
Purpose
Transcranial ultrasound stimulation
Study Objective
To evaluate whether glymphatic transport can be mechanically manipulated by focused ultrasound (FUS) sonication of circulating microbubbles (MBs).
Animal model / Human subject
mouse, C57BL/6, 8–12 weeks, male
Disease model
healthy
Targeted brain region(s)
Thalamus
Cargo name and characteristics
Fluorescently labeled albumin — protein tracer (fluorescently tagged albumin) administered intranasally as a fluid tracer (also delivered via intracisternal magna for comparison)
Route of administration
intranasal administration; intracisternal magna injection
Outcomes and Safety
Summary of Outcomes
FUS combined with microbubbles (FUSMB) mechanically enhanced glymphatic transport of fluorescent albumin, promoting perivascular accumulation and parenchymal penetration of intranasally delivered tracers.
Duration of biological effect
15 min
Safety-related matter
No immediate adverse effects were reported: enhanced tracer transport was not due to trans‑BBB leakage and blood levels of albumin were not increased. However, the authors note prior studies showing transient astrocyte reactivity and microglial activation 3–48 h after FUSMB (which resolve over days) and that delayed biological effects were not assessed in this study.
Brain Region
Ultrasound Parameters
Ultrasound instrument
single-element focused ultrasound transducer (Vantage 256, Verasonics)
FUS Frequency
1.5 MHz
FUS Intensity
not reported
FUS Pressure
0.45 MPa
FUS Mode
not reported
Pulse duration
10 ms
Duration of a single FUS session
120 s
Treatment frequency
single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search